Professors Blackstone and Fuhr on the Benefits of Biosimilar Competition

  Benefits from Biosimilar Competition Erwin A. Blackstone and Joseph P. Fuhr, Jr. (For a printable version of this ConsumerGram with its footnotes, please click here biosimilar2-1)   The U.S. is now developing a process for expedited approval of biosimilars. Biopharmaceuticals are far more complex and costly to develop and produce than chemical drugs. Biosimilars […]

Biosimilars and Innovation: Article by Professors Blackstone and Fuhr

Professors Blackstone and Fuhr, both ACI experts, wrote an interesting article on the tradeoff of increased competition vs. increased innovation and the effects on drug prices.   The full citation is: Blackstone, Erwin A. and Fuhr, Joseph P., Jr., “Biosimilars and Innovation: An Analysis of the Possibility of Increased Competition in Biopharmaceuticals,” Future Medicinal Chemistry, vol 2, no. […]

“Think Tank: Net Neutrality Rules Harmful, Unnecessary” — Wireless Week Cites ACI Study on Innovation and Links To Video Interviews

To read Maisie Ramsay’s Wireless Week article “Think Tank: Net Neutrality Rules Harmful, Unnecessary,” please click here. Click Here for ACI’s Entire Study — innovation-final Click Here for ACI’s Summary Release Click Here for NextGen Web summary and vidoes

Study Finds Unregulated Broadband Market is Key to Innovation

Net Neutrality Will Hurt Private Investment, Impede Consumer Friendly Innovations WASHINGTON – The American Consumer Institute released today a study on innovation by companies in the Internet ecosystem.  The study, which surveyed available data and literature, found that broadband network providers are a leading source of both innovation and new investment in Internet infrastructures.    […]